AI-generated summary
This review describes photobiomodulation (red or near-infrared light) as a possible approach for traumatic brain injury and stroke. The authors report that small animal studies of acute injury showed improved neurological function and reduced inflammation and cell death, and that small human studies in healthy volunteers and chronic TBI patients reported gains in blood flow, memory, cognition or sleep. The abstract itself does not report a pooled effect or certainty rating.
- Who or what was studied
- Animal models of acute TBI, healthy human volunteers and patients with chronic effects of TBI
- Wavelengths
- 600, 1100 nm
- Limits stated in the abstract
- The abstract describes a narrative overview of mostly small animal and human studies and does not state sample sizes, controls or the strength of the evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 600-1100nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Traumatic brain injury, Photobiomodulation, Brain injury, Stroke, Near-infrared, Inflammation, Functional magnetic resonance imaging, Cerebral blood flow. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.